Ardelyx, Inc. is dedicated to discovering, developing, and commercializing innovative medicines for unmet medical needs. The company has two approved products, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor), with international partnerships for their development and commercialization. Ardelyx's focus on first-in-class treatments positions it as a leader in addressing significant health challenges.
Ardelyx is a publicly traded commercial biopharmaceutical company that discovers, develops, and commercializes innovative first-in-class medicines. The Area Business Director (Gastroenterology) will cultivate a strong direct customer-facing presence with gastroenterology healthcare providers and their staff, promoting Ardelyx's novel mechanism medicines that meet important clinical needs.
Ardelyx, Inc. is dedicated to discovering, developing, and commercializing innovative medicines for unmet medical needs. The company has two approved products, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor), with international partnerships for their development and commercialization. Ardelyx's focus on first-in-class treatments positions it as a leader in addressing significant health challenges.
Ardelyx, Inc.